← Back to all trials
Active Not Recruiting
NCT01471834
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
Conditions: High Blood Pressure
Sex: All
Ages: 21 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: CVRx, Inc.
Location: University of Calgary Calgary Alberta
Summary
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Eligibility Criteria
Inclusion Criteria:
* Actively participating in the Neo Non-Randomized Hypertension Study.
* Have signed a revised approved informed consent form for continued participation in this study.
Exclusion Criteria:
* Treating physician decision that the subject should not continue with therapy.
Source: ClinicalTrials.gov (NCT01471834). StuddyBuddy aggregates publicly available trial information.
